03 May 2022
13:56 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022
|
20102020 Medical Services |
Change in Capital |
21 Apr 2022
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.
|
20102020 Medical Services |
Sales |
04 Apr 2022
15:56 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022
|
20102020 Medical Services |
New |
25 Mar 2022
07:15 CET |
EUROFINS SCIENT. |
EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES
|
20102020 Medical Services |
General meeting / Board Meeting |
02 Mar 2022
11:24 CET |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022
|
20102020 Medical Services |
New |
22 Feb 2022
07:15 CET |
EUROFINS SCIENT. |
Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023
|
20102020 Medical Services |
Sales |
09 Feb 2022
18:00 CET |
EUROFINS SCIENT. |
Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam
|
20102020 Medical Services |
New |
02 Feb 2022
12:48 CET |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2022
|
20102020 Medical Services |
New |
21 Jan 2022
16:02 CET |
EUROFINS SCIENT. |
Eurofins’ empowerDX Launches PFAS Exposure™ in the U.S, the First At-Home Blood Test to Detect and Measure 40+ PFAS Compounds
|
20102020 Medical Services |
New |
10 Jan 2022
15:05 CET |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2021
|
20102020 Medical Services |
New |
10 Dec 2021
07:30 CET |
EUROFINS SCIENT. |
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.
|
20102020 Medical Services |
New |
03 Dec 2021
10:42 CET |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2021
|
20102020 Medical Services |
New |
01 Dec 2021
09:00 CET |
EUROFINS SCIENT. |
Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B
|
20102020 Medical Services |
New |
26 Nov 2021
17:48 CET |
EUROFINS SCIENT. |
Eurofins Technologies Announces Launch of RT PCR kIts for Rapid Detection of SARS-CoV-2 Variant B.1.1529
|
20102020 Medical Services |
New |
05 Nov 2021
10:28 CET |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2021
|
20102020 Medical Services |
New |
27 Oct 2021
17:50 CEST |
EUROFINS SCIENT. |
Eurofins Has Entered a Liquidity Contract With Kepler Cheuvreux
|
20102020 Medical Services |
New |
21 Oct 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Delivers Strong Organic Growth of 11.7% in Q3 2021, Above Expectations and Raises Its Objective For 2021
|
20102020 Medical Services |
Sales |
19 Oct 2021
17:45 CEST |
EUROFINS SCIENT. |
Eurofins Responds to Increased Demand For COVID-19 Testing at Schools With Cost-effective Testing Programmes for the Educational Sector
|
20102020 Medical Services |
New |
05 Oct 2021
13:19 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2021
|
20102020 Medical Services |
New |
01 Oct 2021
07:15 CEST |
EUROFINS SCIENT. |
Court Rules in Eurofins Viracor’s favor in Patent Infringement Case
|
20102020 Medical Services |
New |
27 Sep 2021
07:00 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
|
20102020 Medical Services |
New |
10 Sep 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Will Be Included in the CAC 40 Index from September 17
|
20102020 Medical Services |
New |
06 Sep 2021
18:03 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2021
|
20102020 Medical Services |
New |
05 Aug 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Core Business Sets Record Performance in Q2 2021 With 25% Organic Growth Year-on-year
|
20102020 Medical Services |
Sales |
04 Aug 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services and Grows Its Position in Dermatology Drug Testing
|
20102020 Medical Services |
New |
03 Aug 2021
15:43 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2021
|
20102020 Medical Services |
New |
08 Jul 2021
18:37 CEST |
EUROFINS SCIENT. |
Eurofins Viracor Invests in Innovation with the Launch of Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Testing
|
20102020 Medical Services |
New |
07 Jul 2021
18:00 CEST |
EUROFINS SCIENT. |
Eurofins: TruGraf Contracted With Humana for In-network Coverage of Medicare Kidney Transplant Patients
|
20102020 Medical Services |
News contracts |
02 Jul 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins opens Europe-wide COVID-19 testing centre network to facilitate summer travel
|
20102020 Medical Services |
New |
01 Jul 2021
17:10 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2021
|
20102020 Medical Services |
Other subject |
28 Jun 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market
|
20102020 Medical Services |
New |
04 Jun 2021
14:49 CEST |
EUROFINS SCIENT. |
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 May 2021
|
20102020 Medical Services |
Share introduction and issues |
04 Jun 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Core Business Strong Organic Growth Further Accelerates in April
|
20102020 Medical Services |
New |
03 Jun 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins Launches a New Multiplex PCR Assay for Rapid Detection of the B.1.617 “India” SARS-CoV-2 Variant
|
20102020 Medical Services |
New |
27 May 2021
18:33 CEST |
EUROFINS SCIENT. |
Eurofins Awarded U.S. Government Agreement to Expand National COVID-19 Testing
|
20102020 Medical Services |
New |
25 May 2021
07:20 CEST |
EUROFINS SCIENT. |
Eurofins Expands Its Global Sequencing and Mutation-Specific PCR Capabilities to Detect COVID-19 Variants of Concern and of Interest
|
20102020 Medical Services |
New |
21 May 2021
18:52 CEST |
EUROFINS SCIENT. |
Eurofins’ empowerDX At-home COVID-19 Testing Kit Receives EUA For Children Three Years and Older
|
20102020 Medical Services |
New |
19 May 2021
19:55 CEST |
EUROFINS SCIENT. |
Eurofins Announces the Success of Its Tender Offers on Three of Its Existing Bonds
|
20102020 Medical Services |
New |
17 May 2021
07:15 CEST |
EUROFINS SCIENT. |
Eurofins at the Forefront of Innovation With New Developments for Detection and Identification of Emerging COVID-19 Variants of Concern
|
20102020 Medical Services |
New |
11 May 2021
18:43 CEST |
EUROFINS SCIENT. |
Eurofins Successfully Prices New EUR 750m 10-year 0.875%-coupon Senior Unsecured Bonds
|
20102020 Medical Services |
New |
10 May 2021
10:58 CEST |
EUROFINS SCIENT. |
Eurofins Announces Its Intention to Issue New Euro Bonds of Benchmark Size to Refinance Part of Its Existing Bonds
|
20102020 Medical Services |
New |